 0001683168-17-001945.txt : 20170803 0001683168-17-001945.hdr.sgml : 20170803 20170803152436 accession number:		0001683168-17-001945 conformed submission type:	sc 13d public document count:		1 filed as of date:		20170803 date as of change:		20170803 subject company:	 	company data:	 		company conformed name:			iiot-oxys, inc. 		central index key:			0001290658 		standard industrial classification:	wholesale-drugs proprietaries & druggists' sundries [5122] 		irs number:				562415252 		state of incorporation:			ut 		fiscal year end:			1231 	filing values: 		form type:		sc 13d 		sec act:		1934 act 		sec file number:	005-87607 		film number:		171004596 	business address:	 		street 1:		705 cambridge st. 		city:			cambridge 		state:			ma 		zip:			02141 		business phone:		(617)500-5101 	mail address:	 		street 1:		705 cambridge st. 		city:			cambridge 		state:			ma 		zip:			02141 	former company:	 		former conformed name:	gotham capital holdings, inc. 		date of name change:	20150805 	former company:	 		former conformed name:	creative beauty supply of new jersey corp 		date of name change:	20040517 filed by:		 	company data:	 		company conformed name:			dibiase giro 		central index key:			0001712890 	filing values: 		form type:		sc 13d 	mail address:	 		street 1:		705 cambridge st. 		city:			cambridge 		state:			ma 		zip:			02141 sc 13d 1 dibiase_13d.htm schedule 13d united states securities and exchange commission washington, d.c. 20549 schedule 13d under the securities exchange act of 1934 (amendment no. ____) iiot-oxys, inc. (name of issuer) common stock, $0.001 par value per share (title of class of securities) 44963m 104 (cusip number) giro dibiase 705 cambridge street cambridge, ma 02141 (617) 755-1590 (name, address and telephone number of person authorized to receive notices and communications) july 28, 2017 (date of event which requires filing of this statement) if the filing person has previously filed a statement on schedule 13g to report the acquisition which is the subject of this schedule 13d, and is filing this schedule because of &sect;&sect; 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box o . note: schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. see rule 240.13d-7 for other parties to whom copies are to be sent. * the remainder of this cover page shall be filled out for a reporting person&rsquo;s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. the information required on the remainder of this cover page shall not be deemed to be &ldquo;filed&rdquo; for the purpose of section 18 of the securities exchange act of 1934 (the &ldquo;act&rdquo;) or otherwise subject to the liabilities of that section of the act but shall be subject to all other provisions of the act (however, see the notes). 1 1 name of reporting person giro dibiase i.r.s. identification no. of above person (entities only) 2 check the appropriate box if a member of a group* (a) &#9744; (b) &#9744; 3 sec use only 4 source of funds* pf 5 check if disclosure of legal proceedings is required pursuant to items 2(d) or 2(e) &#9744; 6 citizenship or place of organization united states number of shares beneficially owned by each reporting person with 7 sole voting power 3,000,000 shares 8 shared voting power 0 9 sole dispositive power 3,000,000 shares 10 shared dispositive power 0 11 aggregate amount beneficially owned by each reporting person 3,000,000 shares 12 check box if the aggregate amount in row (11) excludes certain shares* 13 percent of class represented by amount in row (11) 7.8% 14 type of reporting person* in 2 item 1. security and issuer. this schedule 13d statement relates to shares of common stock, $0.001 par value per share (the &ldquo; common stock &rdquo;), of iiot-oxys, inc., formerly known as gotham capital holdings, inc., a new jersey corporation (the &ldquo; issuer &rdquo;). the principal executive offices of the issuer are located at 705 cambridge street, cambridge, ma 02141. neither the present filing nor anything contained herein shall be construed as an admission that any reporting person constitutes a &ldquo;person&rdquo; for any purpose other than for compliance with section 13(d) of the securities exchange act of 1934, as amended. item 2. identity and background this schedule 13d statement is being filed by giro dibiase, an individual (the &ldquo; reporting person &rdquo;). mr. dibiase is also a director, president and chief executive officer of the issuer and is a citizen of the united states. the principal business address of the reporting person is 705 cambridge street, cambridge, ma 02141. during the last five years, the reporting person (i) has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or, (ii) was not a party to a civil proceeding of a judicial or administrative body of competent jurisdiction where as a result of such proceeding, there was or is a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. item 3. source and amount of funds or other consideration on july 28, 2017, the issuer closed (the &ldquo; closing &rdquo;) the securities exchange agreement (the &ldquo; exchange agreement &rdquo;) with oxys corporation, a nevada corporation (&ldquo; oxys &rdquo;), and its shareholders. as a result of the closing of the exchange agreement, oxys became a wholly-owned subsidiary of the issuer, and each shareholder of oxys exchanged their shares for shares of the issuer. prior to closing, mr. dibiase owned 3,000,000 shares of oxys, which converted into 3,000,000 shares of the issuer at closing. the consideration used by mr. dibiase to acquire its shares of the issuer was an exchange of shares of oxys owned by mr. dibiase, for which he paid $900. item 4. purpose of transaction except as disclosed below, the reporting person has acquired beneficial ownership of the securities for investment purposes and will evaluate his investment in the securities on a continual basis. the reporting person has no plans or proposals that would relate to or would result in: the acquisition of additional securities of the issuer or the disposition of presently-owned securities of the issuer; any extraordinary corporate transaction involving the issuer; a sale or transfer of a material amount of assets of the issuer; any material change in the present capitalization or dividend policy of the issuer; any material change in the operating policies or corporate structure of the issuer; any change in the issuer's charter or by-laws; the shares of the issuer ceasing to be authorized to be quoted in the over-the-counter market; or causing the issuer to become eligible for termination of registration pursuant to section 12(g)(4) of the securities exchange act of 1934. the reporting person, however, reserve the right, at a later date, to effect one or more of such changes or transactions in the number of shares they may be deemed to beneficially own. the shares of the issuer were acquired by the reporting person with the intent to effect a reverse acquisition of the issuer, whereby the reporting person, with the other shareholders of oxys, obtained voting and management control of the issuer. item 5. interest in securities of the issuer. pursuant to rule 13d-3(a), at the close of business on july 28, 2017, the issuer had 38,453,328 shares of common stock issued and outstanding as reported in the issuer&rsquo;s current report on form 8-k, filed with the commission on august 3, 2017. of the total shares beneficially owned by the reporting person, mr. dibiase beneficially owns 3,000,000 shares of common stock which constitutes approximately 7.8% of the outstanding shares of the issuer. the reporting person has not effected any transactions in the common stock of the issuer during the past 60 days, except as described in this schedule 13d. 3 item 6. contracts, arrangements, understandings or relationships with respect to securities of the issuer. the disclosure in items 2 and 3 is incorporated by reference herein. the reporting person receives $2,500 per month as compensation for part-time services performed for oxys. this arrangement, which began on june 1, 2017, is not evidenced by a written agreement or contract. item 7. materials to be filed as exhibits. incorporated by reference filed herewith exhibit description form file no. exhibit no. filing date securities exchange agreement dated march 16, 2017 8-k 000-50773 2.1 8/3/17 signatures after reasonable inquiry and to the best of my knowledge and belief, i certify that the information set forth in this statement is true, complete and correct. dated: august 3, 2017 /s/ giro dibiase giro dibiase 